Chen Jin-Long
- SEC CIK
- 0001642996
No open-market purchases or sales filed in the past year.
Current role at each company
- TNYA Tenaya Therapeutics, Inc.Directoras of Jun 12, 2023
- NGM NGM Biopharmaceuticals IncChief Scientific Officeras of Mar 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Chen Jin-Long as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NGM NGM Biopharmaceuticals Inc
Chief Scientific Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2021 (view filing) | Aug 9-10 | 2 days | Chen Jin-LongChief Scientific Officer | SSale | −30.0K | $23.81 | −$714.2K | −3.0%959.4K after | 4 lots |
| Sep 14, 2021 (view filing) | Sep 13-14 | 1 day | Chen Jin-LongChief Scientific Officer | SSale | −30.0K | $25.84 | −$775.3K | −3.1%929.4K after | 5 lots |
| Oct 13, 2021 (view filing) | Oct 11-12 | 2 days | Chen Jin-LongChief Scientific Officer | SSale | −30.0K | $20.28 | −$608.3K | −3.2%899.4K after | 2 lots |
| Nov 16, 2021 (view filing) | Nov 15 | 1 day | Chen Jin-LongChief Scientific Officer | SSale | −30.0K | $19.73 | −$591.8K | −3.3%869.4K after | 2 lots |
| Dec 7, 2021 (view filing) | Dec 6-7 | 1 day | Chen Jin-LongChief Scientific Officer | SSale | −30.0K | $18.41 | −$552.1K | −3.2%908.9K after | 2 lots |
| Jan 18, 2023 (view filing) | Jan 17 | 1 day | Chen Jin-LongChief Scientific Officer | SSale | −85.1K | $5.15 | −$438.2K | −8.6%908.9K after |